The Milford Board of Health wishes to share the following statement from the COVID-19 Command Response Center:
“In response to today’s recommendation from the FDA and CDC to pause J&J vaccines due to an extremely rare condition reported in 6 individuals nationwide, the Department of Public Health directed all providers to immediately pause administration of the J&J vaccine until federal health experts investigate this matter. This action is being taken out of an abundance of caution as the FDA and CDC review these 6 cases, none of which are known to be linked to Massachusetts. The FDA has reported over 6.8M doses of J&J have been administered nationwide. Individuals who have received a J&J vaccine should contact their physician if they have concerns.” - Command Spokesperson
- The FDA has reported that as of 4/12, 6.8m+ doses of the J&J vaccine have been administered in the U.S. CDC & FDA are reviewing data involving 6 reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the vaccine. Right now, these conditions appear to be extremely rare.
- As of April 12th, 181,034 doses of J&J have been administered in Massachusetts.
- CDC will convene a meeting of the Advisory Committee on Immunization Practices (ACIP) on Wednesday to further review these cases and assess their potential significance. FDA will review that analysis as it also investigates.
- Individuals that have appointments scheduled for a J&J vaccine that have questions about their upcoming appointment should contact the provider they booked with directly.
- Individuals are encouraged to contact their physician if they have received the J&J vaccine and have concerns.
|Milford Board of Health Johnson and Johnson Vaccine Update||247.42 KB|